The Role of Helicobacter pylori Infection, and Malnutrition among Type 2 Diabetic Medical Services Patients in the Gaza Strip

Mazen A. El-Sakka, Ektemal M. Abu Jabal, Luay M. Nasser

Medical Service, Gaza, Palestine.
Nutrition Department, Ministry of National Economy, Gaza, Palestine.
Pharmacognosy Department, Faculty of Pharmacy, Al Azhar University-Gaza, Gaza, Palestine.

DOI: 10.4236/ijcm.2013.412096                

Abstract

Background: Diabetes means the blood glucose, which is too high or too low. With Type 2 DM, the more common type, the body does not make or use insulin well. In patients with DM, Helicobacter pylori is one of the most common infections worldwide. Available data on the possible association between H. pylori infection and DM are contradictory. There are a few studies in the Middle East, and this study is the pioneer study, in the Medical Services Clinics in Gaza strip. Aims: This study was conducted to reveal the prevalence of H. pylori infection, malnutrition, insulin resistance among T2DM patients, to describe the dietary requirements of T2DM patients, finally to evaluate the current information about diet, and lifestyle in the prevention of H. pylori, and malnutrition. Methodology: A cross-sectional study was conducted in the Medical Services Clinics in Gaza Strip, and there were 129 patients included in this study. Data were collected through hematological information and structured interview questionnaire. Results: Highly significant percentage of H. pylori (70%) among the DM patients includes in the study, but not indicates any significant association between gender and H. pylori status. Conclusion: H. pylori patients should update their sugar level values in the record, and should get exercise and diet plan for every meal.

Keywords

Type 2 Diabetes Mellitus (T2DM); Helicobacter pylori (H. pylori); Insulin Resistance (IR); Malnutrition

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	A. Baradaran and H. Nasri, “Helicobacter pylori Specific IgG Antibody and Serum Magnesium in Type-2 Diabetes Mellitus Chronic Kidney Disease Patients,” Saudi Journal of Kidney Diseases and Transplantation, Vol. 22, No. 2, 2011, pp. 282-285.
[2]	National Institutes of Health (NIH), “A Service of the U.S. National Library of Medicine. Annual Report,” 2012,
[3]	S. A. Polyzos, J. Kountouras, C. Zavos and G. Deretzi, “The Association between Helicobacter pylori Infection and Insulin Resistance; Part 1,” Heicobacter Journal, Vol. 16, No. 1, 2010, pp. 76-88.
[4]	M. D. Goutham Rao, “Insulin Resistance Syndrome,” American Family Physician, Vol. 63, No. 6, 2001, pp. 1159-1164.
[5]	R. Preidt, “Type of Bacteria May Be Linked to Diabetes, The Association between H. pylori Infection, Type 2 Disease,” A Service of the US National Library of Medicine, 2012.
[6]	W. I. Albaker, “Helicobacter pylori Infection and Its Relationship to Metabolic Syndrome: Is It a Myth or Fact?” Saudi Journal of Gastroenterology, Vol. 17, No. 3, 2011, pp. 165-169. http://dx.doi.org/10.4103/1319-3767.80377
[7]	R. Gen, M. Demir and H. Ataseven, “Effect of Helicobacter pylori Eradication on Insulin Resistance, Serum Lipids and Low-Grade Inflammation,” Southern Medical Journal, Vol. 103, No. 3, 2010, pp. 190-196. http://dx.doi.org/10.1097/SMJ.0b013e3181cf373f
[8]	Medical Services Commission, Annual Report 2010/ 2011.
[9]	A. Bener, S. A. Uduman, A. Ameen, et al., “Prevalence of Helicobacter pylori Infection among Low Socio-Economic Workers,” Journal of Communicable Diseases, Vol. 34, No. 3, 2002, pp. 179-184.
[10]	L. Simon’s, J. Tornoczky, M. Toth, M. Jambor and Z. Sudar, “The Significance of Campylobacter pylori Infection in Gastroenterologic and Diabetic Practice,” Orvosi Hetilap, Vol. 130, No. 25, 1989, pp. 1325-1329.
[11]	A. Cuevas, J. Miquel, M. Reyes and F. Nervi, “Diet as a Risk Factor for Cholesterol Gallstone Disease,” Journal of the American College of Nutrition, Vol. 23, No. 3, 2004, pp. 187-196.
[12]	R. Liu, “Health Benefits of Fruit and Vegetables Are from Additive and Synergistic Combinations of Phytochemicals,” American Journal of Clinical Nutrition, Vol. 78, No. 3, 2003, pp. 517-520.